The global market for Poly Lactic-co-Glycolic Acid (PLGA) was estimated at US$136.9 Million in 2024 and is projected to reach US$349.2 Million by 2030, growing at a CAGR of 16.9% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. The report includes the most recent global tariff developments and how they impact the Poly Lactic-co-Glycolic Acid (PLGA) market.
The rising demand for biodegradable polymers in healthcare is a key driver for PLGA’s adoption. The global burden of chronic diseases, increasing need for targeted drug delivery, and advancements in tissue regeneration have significantly boosted PLGA usage in pharmaceutical and biomedical industries. Regulatory approvals from the U.S. FDA, European Medicines Agency (EMA), and other health agencies have further solidified its role in next-generation medical treatments.
Additionally, PLGA is highly tunable, allowing scientists to modify its degradation rate, mechanical properties, and drug-release kinetics by adjusting the ratio of lactic acid (LA) to glycolic acid (GA). This flexibility has led to widespread applications in nanoparticles, scaffold engineering, biosensors, and bioresorbable implants.
One of the most significant innovations is PLGA-based nanoparticles and microparticles for controlled drug delivery. Nanoparticle-based drug carriers improve drug stability, solubility, and bioavailability, allowing for sustained and localized drug release. PLGA nanoparticles are widely used in oncology, gene therapy, vaccine delivery, and neurodegenerative disease treatments, enabling targeted delivery with minimal side effects.
Personalized medicine and gene therapy advancements are also driving demand for PLGA in next-generation drug delivery systems. Scientists are engineering PLGA-based nanocarriers for mRNA, CRISPR-based gene editing, and personalized cancer treatments, offering precision medicine solutions. The success of mRNA-based vaccines (such as COVID-19 vaccines) has accelerated research into PLGA-based lipid nanoparticle (LNP) alternatives for future vaccine formulations.
Additionally, 3D-printed PLGA scaffolds are transforming tissue engineering and regenerative medicine. PLGA’s biodegradable and bioresorbable properties make it ideal for bone, cartilage, and soft tissue regeneration. 3D-printed PLGA biomaterials are now used in personalized implants, orthopedic grafts, and bioprinting applications, enabling customized medical solutions for patients.
The integration of PLGA with bioactive molecules (such as growth factors, peptides, and proteins) is further expanding its role in wound healing, dental applications, and nerve regeneration. Scientists are developing PLGA-based hydrogels, nanofibers, and composite biomaterials for advanced wound dressings and surgical applications, improving patient recovery outcomes.
With ongoing innovations in nanomedicine, 3D bioprinting, and bioengineered implants, the PLGA market is set for rapid expansion. As healthcare providers, pharmaceutical companies, and biotech firms prioritize biodegradable and patient-friendly materials, PLGA will remain a key player in the future of drug delivery, regenerative medicine, and advanced medical device development.
Segments: Composition (High Lactic Acid Grade, High Glycolic Acid Grade); Processibility (Extrusion, Injection Molding, Other Processibilities); Application (Medical Application, Non-Medical Application); End-Use (Healthcare End-Use, Biotech Firms End-Use, Medical Institutions End-Use, Packaging End-Use, Textile End-Use, Agriculture End-Use, Other End-Uses)
Geographic Regions/Countries: World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.
The report analyzes the Poly Lactic-co-Glycolic Acid (PLGA) market in terms of units by the following Segments, and Geographic Regions/Countries:
Segments:
Composition (High Lactic Acid Grade, High Glycolic Acid Grade); Processibility (Extrusion, Injection Molding, Other Processibilities); Application (Medical Application, Non-Medical Application); End-Use (Healthcare End-Use, Biotech Firms End-Use, Medical Institutions End-Use, Packaging End-Use, Textile End-Use, Agriculture End-Use, Other End-Uses)
Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.
Select Competitors (Total 47 Featured\):
The analysts continuously track trade developments worldwide, drawing insights from leading global economists and over 200 industry and policy institutions, including think tanks, trade organizations, and national economic advisory bodies. This intelligence is integrated into forecasting models to provide timely, data-driven analysis of emerging risks and opportunities.
Global Poly (Lactic-co-Glycolic Acid) (PLGA) Market - Key Trends & Drivers Summarized
Why Is PLGA Gaining Importance in Biomedical and Pharmaceutical Applications?
Poly (Lactic-co-Glycolic Acid) (PLGA) is a biodegradable and biocompatible polymer widely used in drug delivery systems, medical implants, tissue engineering, and regenerative medicine. Its ability to degrade into non-toxic byproducts (lactic acid and glycolic acid) makes it an ideal material for controlled drug release, absorbable sutures, orthopedic fixation devices, and nano/microparticle-based therapeutics.The rising demand for biodegradable polymers in healthcare is a key driver for PLGA’s adoption. The global burden of chronic diseases, increasing need for targeted drug delivery, and advancements in tissue regeneration have significantly boosted PLGA usage in pharmaceutical and biomedical industries. Regulatory approvals from the U.S. FDA, European Medicines Agency (EMA), and other health agencies have further solidified its role in next-generation medical treatments.
Additionally, PLGA is highly tunable, allowing scientists to modify its degradation rate, mechanical properties, and drug-release kinetics by adjusting the ratio of lactic acid (LA) to glycolic acid (GA). This flexibility has led to widespread applications in nanoparticles, scaffold engineering, biosensors, and bioresorbable implants.
How Are Innovations in PLGA Technology Enhancing Its Market Potential?
The PLGA market is evolving rapidly with advancements in nanotechnology, personalized medicine, and 3D-printed biomedical materials.One of the most significant innovations is PLGA-based nanoparticles and microparticles for controlled drug delivery. Nanoparticle-based drug carriers improve drug stability, solubility, and bioavailability, allowing for sustained and localized drug release. PLGA nanoparticles are widely used in oncology, gene therapy, vaccine delivery, and neurodegenerative disease treatments, enabling targeted delivery with minimal side effects.
Personalized medicine and gene therapy advancements are also driving demand for PLGA in next-generation drug delivery systems. Scientists are engineering PLGA-based nanocarriers for mRNA, CRISPR-based gene editing, and personalized cancer treatments, offering precision medicine solutions. The success of mRNA-based vaccines (such as COVID-19 vaccines) has accelerated research into PLGA-based lipid nanoparticle (LNP) alternatives for future vaccine formulations.
Additionally, 3D-printed PLGA scaffolds are transforming tissue engineering and regenerative medicine. PLGA’s biodegradable and bioresorbable properties make it ideal for bone, cartilage, and soft tissue regeneration. 3D-printed PLGA biomaterials are now used in personalized implants, orthopedic grafts, and bioprinting applications, enabling customized medical solutions for patients.
The integration of PLGA with bioactive molecules (such as growth factors, peptides, and proteins) is further expanding its role in wound healing, dental applications, and nerve regeneration. Scientists are developing PLGA-based hydrogels, nanofibers, and composite biomaterials for advanced wound dressings and surgical applications, improving patient recovery outcomes.
Why Is Demand for PLGA Growing Across Healthcare and Biomedical Sectors?
The increasing use of PLGA across pharmaceutical, medical device, and biotechnology industries is driving market expansion. Key sectors benefiting from PLGA’s properties include:- Pharmaceutical Drug Delivery: PLGA is extensively used in long-acting injectable drugs, microsphere-based formulations, and targeted nanoparticle therapeutics. PLGA-based drug delivery systems improve therapeutic efficacy, reduce dosing frequency, and enhance patient compliance, making them ideal for oncology, diabetes, cardiovascular diseases, and neurodegenerative disorders.
- Medical Implants & Sutures: The absorbable sutures, orthopedic pins, screws, and fixation devices market relies heavily on PLGA due to its biodegradability and biocompatibility. PLGA-based implants eliminate the need for surgical removal, reducing patient discomfort and post-operative complications.
- Tissue Engineering & Regenerative Medicine: PLGA scaffolds are being used for bone regeneration, cartilage repair, and soft tissue engineering. The development of PLGA-based stem cell delivery platforms has further expanded its applications in wound healing, vascular grafts, and nerve regeneration.
- Biodegradable Medical Devices: PLGA is being used in stent coatings, biosensors, and nanofiber-based wound dressings. The demand for biodegradable medical devices and implants is growing as hospitals and surgeons seek minimally invasive and patient-friendly solutions.
- Vaccine & Gene Therapy Development: PLGA nanoparticles are increasingly utilized in mRNA vaccine stabilization, DNA delivery, and CRISPR gene-editing platforms. Research into PLGA-based adjuvants and immunotherapies is expected to accelerate with the global rise in infectious disease preparedness.
What Factors Are Driving the Growth of the PLGA Market?
The growth in the PLGA market is driven by technological advancements, increasing demand for biodegradable medical solutions, and expanding applications in pharmaceuticals and regenerative medicine.- Rising Demand for Controlled Drug Delivery: The shift from conventional drug formulations to long-acting injectables and targeted nanoparticle therapeutics has significantly increased PLGA usage in drug delivery applications.
- Advancements in Biodegradable & Bioresorbable Medical Devices: The rising adoption of bioabsorbable sutures, stents, and implants is driving demand for PLGA-based medical devices. As hospitals and surgical centers prioritize patient-friendly solutions, PLGA’s role in post-operative healing and implantable drug-eluting devices is expanding.
- Increasing Focus on Regenerative Medicine: The growth of tissue engineering and stem cell therapy research has positioned PLGA as a leading biomaterial for 3D-printed scaffolds, artificial organ regeneration, and personalized medicine applications.
- Government & Regulatory Support for Biodegradable Polymers: Regulatory agencies such as the FDA and EMA are promoting biodegradable and bioresorbable materials for medical use, leading to increased investment in PLGA-based biopolymers.
- Growing Investments in Vaccine & Nanomedicine Research: The success of mRNA vaccine platforms and targeted nanoparticle drug delivery has accelerated R&D in PLGA-based nanocarriers for next-generation vaccines, immunotherapies, and antiviral treatments.
- Sustainability & Biodegradability Initiatives: The global shift toward eco-friendly medical solutions is driving interest in biodegradable polymers for medical waste reduction, positioning PLGA as a sustainable alternative to petroleum-based medical plastics.
With ongoing innovations in nanomedicine, 3D bioprinting, and bioengineered implants, the PLGA market is set for rapid expansion. As healthcare providers, pharmaceutical companies, and biotech firms prioritize biodegradable and patient-friendly materials, PLGA will remain a key player in the future of drug delivery, regenerative medicine, and advanced medical device development.
Report Scope
The report analyzes the Poly Lactic-co-Glycolic Acid (PLGA) market, presented in terms of market value (US$ Thousand). The analysis covers the key segments and geographic regions outlined below.Segments: Composition (High Lactic Acid Grade, High Glycolic Acid Grade); Processibility (Extrusion, Injection Molding, Other Processibilities); Application (Medical Application, Non-Medical Application); End-Use (Healthcare End-Use, Biotech Firms End-Use, Medical Institutions End-Use, Packaging End-Use, Textile End-Use, Agriculture End-Use, Other End-Uses)
Geographic Regions/Countries: World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.
Key Insights:
- Market Growth: Understand the significant growth trajectory of the High Lactic Acid Grade segment, which is expected to reach US$255.7 Million by 2030 with a CAGR of a 18.3%. The High Glycolic Acid Grade segment is also set to grow at 13.6% CAGR over the analysis period.
- Regional Analysis: Gain insights into the U.S. market, estimated at $37.3 Million in 2024, and China, forecasted to grow at an impressive 22.5% CAGR to reach $77.8 Million by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.
Why You Should Buy This Report:
- Detailed Market Analysis: Access a thorough analysis of the Global Poly Lactic-co-Glycolic Acid (PLGA) Market, covering all major geographic regions and market segments.
- Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
- Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Poly Lactic-co-Glycolic Acid (PLGA) Market.
- Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.
Key Questions Answered:
- How is the Global Poly Lactic-co-Glycolic Acid (PLGA) Market expected to evolve by 2030?
- What are the main drivers and restraints affecting the market?
- Which market segments will grow the most over the forecast period?
- How will market shares for different regions and segments change by 2030?
- Who are the leading players in the market, and what are their prospects?
Report Features:
- Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2024 to 2030.
- In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
- Company Profiles: Coverage of players such as Pharmaceutical Drug Delivery: PLGA is extensively used in long-acting injectable drugs, microsphere-based formulations, and targeted nanoparticle therapeutics. PLGA-based drug delivery systems improve therapeutic efficacy, reduce dosing frequency, and enhance patient compliance, making them ideal for oncology, diabetes, cardiovascular diseases, and neurodegenerative disorders.
- Medical Implants & Sutures: The absorbable sutures, orthopedic pins, screws, and fixation devices market relies heavily on PLGA due to its biodegradability and biocompatibility. PLGA-based implants eliminate the need for surgical removal, reducing patient discomfort and post-operative complications.
- Tissue Engineering & Regenerative Medicine: PLGA scaffolds are being used for bone regeneration, cartilage repair, and soft tissue engineering. The development of PLGA-based stem cell delivery platforms has further expanded its applications in wound healing, vascular grafts, and nerve regeneration.
- Biodegradable Medical Devices: PLGA is being used in stent coatings, biosensors, and nanofiber-based wound dressings. The demand for biodegradable medical devices and implants is growing as hospitals and surgeons seek minimally invasive and patient-friendly solutions.
- Vaccine & Gene Therapy Development: PLGA nanoparticles are increasingly utilized in mRNA vaccine stabilization, DNA delivery, and CRISPR gene-editing platforms. Research into PLGA-based adjuvants and immunotherapies is expected to accelerate with the global rise in infectious disease preparedness.
What Factors Are Driving the Growth of the PLGA Market?
The growth in the PLGA market is driven by technological advancements, increasing demand for biodegradable medical solutions, and expanding applications in pharmaceuticals and regenerative medicine.
- Rising Demand for Controlled Drug Delivery: The shift from conventional drug formulations to long-acting injectables and targeted nanoparticle therapeutics has significantly increased PLGA usage in drug delivery applications.
- Advancements in Biodegradable & Bioresorbable Medical Devices: The rising adoption of bioabsorbable sutures, stents, and implants is driving demand for PLGA-based medical devices. As hospitals and surgical centers prioritize patient-friendly solutions, PLGA’s role in post-operative healing and implantable drug-eluting devices is expanding.
- Increasing Focus on Regenerative Medicine: The growth of tissue engineering and stem cell therapy research has positioned PLGA as a leading biomaterial for 3D-printed scaffolds, artificial organ regeneration, and personalized medicine applications.
- Government & Regulatory Support for Biodegradable Polymers: Regulatory agencies such as the FDA and EMA are promoting biodegradable and bioresorbable materials for medical use, leading to increased investment in PLGA-based biopolymers.
- Growing Investments in Vaccine & Nanomedicine Research: The success of mRNA vaccine platforms and targeted nanoparticle drug delivery has accelerated R&D in PLGA-based nanocarriers for next-generation vaccines, immunotherapies, and antiviral treatments.
- Sustainability & Biodegradability Initiatives: The global shift toward eco-friendly medical solutions is driving interest in biodegradable polymers for medical waste reduction, positioning PLGA as a sustainable alternative to petroleum-based medical plastics.
With ongoing innovations in nanomedicine, 3D bioprinting, and bioengineered implants, the PLGA market is set for rapid expansion. As healthcare providers, pharmaceutical companies, and biotech firms prioritize biodegradable and patient-friendly materials, PLGA will remain a key player in the future of drug delivery, regenerative medicine, and advanced medical device development.
SCOPE OF STUDY:
The report analyzes the Poly Lactic-co-Glycolic Acid (PLGA) market in terms of units by the following Segments, and Geographic Regions/Countries:
Segments:
Composition (High Lactic Acid Grade, High Glycolic Acid Grade); Processibility (Extrusion, Injection Molding, Other Processibilities); Application (Medical Application, Non-Medical Application); End-Use (Healthcare End-Use, Biotech Firms End-Use, Medical Institutions End-Use, Packaging End-Use, Textile End-Use, Agriculture End-Use, Other End-Uses)
Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.
Select Competitors (Total 47 Featured\):
- Akina, Inc., Ashland Inc., Bezwada Biomedical, LLC, BMG Incorporated, CD Bioparticles and more.
- Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.
Select Competitors (Total 47 Featured):
- Akina, Inc.
- Ashland Inc.
- Bezwada Biomedical, LLC
- BMG Incorporated
- CD Bioparticles
- Corbion N.V.
- Creative PEGWorks
- Evonik Industries AG
- Green Polymer Corporation
- Jinan Daigang Biomaterial Co., Ltd.
- Kureha Corporation
- LACTEL Absorbable Polymers (Durect Corporation)
- Merck KGaA
- Mitsui Chemicals, Inc.
- Nomisma Healthcare Pvt. Ltd.
- Polysciences, Inc.
- SEQENS
- Shandong Keyuan Pharmaceutical Co., Ltd.
- Sigma-Aldrich Corporation
- Wego Chemical Group
Tariff Impact Analysis: Key Insights for 2025
Global tariff negotiations across 180+ countries are reshaping supply chains, costs, and competitiveness. This report reflects the latest developments as of April 2025 and incorporates forward-looking insights into the market outlook.The analysts continuously track trade developments worldwide, drawing insights from leading global economists and over 200 industry and policy institutions, including think tanks, trade organizations, and national economic advisory bodies. This intelligence is integrated into forecasting models to provide timely, data-driven analysis of emerging risks and opportunities.
What’s Included in This Edition:
- Tariff-adjusted market forecasts by region and segment
- Analysis of cost and supply chain implications by sourcing and trade exposure
- Strategic insights into geographic shifts
Buyers receive a free July 2025 update with:
- Finalized tariff impacts and new trade agreement effects
- Updated projections reflecting global sourcing and cost shifts
- Expanded country-specific coverage across the industry
Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERSIV. COMPETITION
1. MARKET OVERVIEW
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
III. MARKET ANALYSIS
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Akina, Inc.
- Ashland Inc.
- Bezwada Biomedical, LLC
- BMG Incorporated
- CD Bioparticles
- Corbion N.V.
- Creative PEGWorks
- Evonik Industries AG
- Green Polymer Corporation
- Jinan Daigang Biomaterial Co., Ltd.
- Kureha Corporation
- LACTEL Absorbable Polymers (Durect Corporation)
- Merck KGaA
- Mitsui Chemicals, Inc.
- Nomisma Healthcare Pvt. Ltd.
- Polysciences, Inc.
- SEQENS
- Shandong Keyuan Pharmaceutical Co., Ltd.
- Sigma-Aldrich Corporation
- Wego Chemical Group
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 77 |
| Published | April 2025 |
| Forecast Period | 2024 - 2030 |
| Estimated Market Value ( USD | $ 136.9 Million |
| Forecasted Market Value ( USD | $ 349.2 Million |
| Compound Annual Growth Rate | 16.9% |
| Regions Covered | Global |
